Therapeutic Potential of Copper Chelation with Triethylenetetramine in Managing Diabetes Mellitus and Alzheimer’s Disease

被引:0
|
作者
Garth J. S. Cooper
机构
[1] Central Manchester University Hospitals NHS Foundation Trust,Centre for Advanced Discovery and Experimental Therapeutics, NIHR Manchester Biomedical Research Centre
[2] University of Manchester,School of Medicine
[3] University of Auckland,School of Biological Sciences and Maurice Wilkins Centre for Molecular Biodiscovery, Faculty of Science
[4] University of Oxford,Department of Pharmacology, Medical Sciences Division
来源
Drugs | 2011年 / 71卷
关键词
Diabetic Nephropathy; TETA; Copper Deficiency; Trientine; Urinary Copper;
D O I
暂无
中图分类号
学科分类号
摘要
This article reviews recent evidence, much of which has been generated by my group’s research programme, which has identified for the first time a previously unknown copper-overload state that is central to the pathogenesis of diabetic organ damage. This state causes tissue damage in the blood vessels, heart, kidneys, retina and nerves through copper-mediated oxidative stress. This author now considers this copper-overload state to provide an important new target for therapeutic intervention, the objective of which is to prevent or reverse the diabetic complications.
引用
收藏
页码:1281 / 1320
页数:39
相关论文
共 50 条
  • [1] Therapeutic Potential of Copper Chelation with Triethylenetetramine in Managing Diabetes Mellitus and Alzheimer's Disease
    Cooper, Garth J. S.
    [J]. DRUGS, 2011, 71 (10) : 1281 - 1320
  • [2] The Case for Abandoning Therapeutic Chelation of Copper Ions Alzheimer's Disease
    Drew, Simon C.
    [J]. FRONTIERS IN NEUROSCIENCE, 2017, 11
  • [3] Commentary: the Case for abandoning therapeutic Chelation of Copper Ions in alzheimer's Disease
    Squitti, Rosanna
    Salustri, Carlo
    Rongioletti, Mauro
    Siotto, Mariacristina
    [J]. FRONTIERS IN NEUROLOGY, 2017, 8
  • [4] Therapeutic Strategies for Alzheimer's Disease in the View of Diabetes Mellitus
    Ohyagi, Yasumasa
    Miyoshi, Katsue
    Nakamura, Norimichi
    [J]. DIABETES MELLITUS: A RISK FACTOR FOR ALZHEIMER'S DISEASE, 2019, 1128 : 227 - 248
  • [5] Diabetes Mellitus and Energy Dysmetabolism in Alzheimer's Disease: Understanding the Relationships and Potential Therapeutic Targets
    Onaolapo, Adejoke Y.
    Ojo, Folusho O.
    Adeleye, Olufunto O.
    Falade, Joshua
    Onaolapo, Olakunle J.
    [J]. CURRENT DIABETES REVIEWS, 2023, 19 (08) : 31 - 45
  • [6] Exploring the therapeutic potential of steroidal alkaloids in managing Alzheimer's disease
    Pandey, Pratima P.
    Kumar, Maushmi S.
    [J]. STEROIDS, 2024, 209
  • [7] Diabetes mellitus and Alzheimer's disease
    Lithner, F
    [J]. DIABETOLOGIA, 1996, 39 (10) : 1242 - 1242
  • [8] Alzheimer's Disease and Diabetes Mellitus
    Lilia Mestizo-Gutierrez, Sonia
    Elena Hernandez-Aguilar, Maria
    Rojas-Duran, Fausto
    Manzo-Denes, Jorge
    Aranda Abreu, Gonzalo Emiliano
    [J]. ENEUROBIOLOGIA, 2014, 5 (10):
  • [9] Metal chelation as a potential therapy for Alzheimer's disease
    Cuajungco, MP
    Fagét, KY
    Huang, XD
    Tanzi, RE
    Bush, AI
    [J]. MOLECULAR BASIS OF DEMENTIA, 2000, 920 : 292 - 304
  • [10] Alzheimer's Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound
    He, Zhijun
    You, Guanying
    Liu, Qiong
    Li, Nan
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)